To me this is an easier NO decision than the Koutchin-Peters...

To me this is an easier NO decision than the Koutchin-Peters decision.

I have suspected from the outset that we were either being raided for our cash, or our shell is being turned into an investment vehicle for PVL.

It certainly feels even more that way now.

I already have enough investments in listed investment companies and funds, and to be honest, if I were to want to invest more in one, it likely wouldn't be PVL. I am in PER as a pure drug company, and I do not see PVL being able to restore shareholder value in PER in any other way. Biotechs are WIN BIG/LOSE BIG. We are currently in the 'lose big' situation due to the failure of ATL1102. I was shocked/disappointed/angry, but it happens. Spreading what little we have left of our shareholder value amongst a bunch of small investments is not going to return us significant shareholder value. There are no 'win bigs' there. Especially if much of our gains are siphoned off in management fees. We would all be better taking our money out and investing it elsewhere.

PVL have given no details of their plan to restore shareholder value in their 'Members Statement' attached to this notice. This was their opportunity to inform us of their intentions, their pathway forward, and their goals. Nothing. Are they going to remain a pure biotech? We don't know. Are they going to use us (and our cash) as an investment shell? We don't know. To me there is far too much risk as to what their intentions are. We simply don't know what they are. Way too much risk in simply 'trusting' these guys to do the right thing by us when there are other alternatives they may choose.

At least with Charmaine and James, it is clear what they intend to do with PER. They intend to remain a biotech. They intend to licence a drug and try to bring it to market. That is their expertise. That is what they were trying to do with ATL1102 until it failed, and that is in line with why I invested in PER.